Introduction: In 2022, the Colombian government approved a law requiring by 2024 the use of Front of Package octagonal warning labels in food products with an excess of nutrients of concern for chronic disease, including sodium, sugar, saturated fat, and trans-fat, as well as non-nutritive sweeteners (NNS). In addition, the government began 2023 by applying a 10% tax on sugar-sweetened beverages and foods that also had warning labels for sodium, sugar and saturated fat. This tax increased to 15% in 2024 and to $20% in 2025.
View Article and Find Full Text PDFTreatment for enteric parasites is a common practice in beef cattle, yet little data is known about the prevalence of nematode and trematode parasite infections in beef cattle in the western United States. Likewise, the data on the efficacy of deworming practices and the presence of anthelmintic resistance (AR) of these parasites in this region is sparse. The current study collected evidence for the presence of nematode and trematode parasites in 18 herds of young beef cattle grazing either dryland or irrigated pasture in northern California as well as on efficacy and evidence of AR in a subgroup of herds.
View Article and Find Full Text PDFBackground: Interest in the study of type 1 diabetes mellitus (T1DM) and multiple sclerosis (MS) has increased because of their significant negative impact on the patient quality of life and the profound implications for the health care system. Although the clinical symptoms of T1DM differ from those of MS, such as pancreatic β-cell failure in T1DM and demyelination in the central nervous system (CNS) in MS, both pathologies are considered as autoimmune-related diseases with shared pathogenic pathways, which include autophagy, inflammation and degeneration, among others. Considering the challenges in obtaining pancreatic β-cells and CNS tissue from patients with T1DM and MS, respectively, it is fundamental to explore alternative methods for evaluating disease status.
View Article and Find Full Text PDFBackground: Current literature and a real-world study suggest that diroximel fumarate (DRF) is safer than dimethyl fumarate (DMF) in the treatment of multiple sclerosis (MS). However, no real-world study to date has significantly addressed the efficacy of this treatment.
Objectives: This study aims to elucidate the safety, tolerability, and efficacy of DRF in a real-world setting, utilizing data from a Spanish national registry of patients commencing DRF therapy post-market introduction.
Severe acute respiratory syndrome coronavirus 2 infection often involves the nervous system, leading to cognitive dysfunctions, fatigue and many other neurological signs that are becoming increasingly recognized. Despite mild forms of the disease accounting for most cases worldwide, research on the pathophysiology driving mild coronavirus disease 2019 (COVID-19) has received little attention. In this respect, recent evidence has pointed out that around 30-40% of non-critical, mild-to-moderate severity COVID-19 survivors may display cognitive disturbances several months post-illness.
View Article and Find Full Text PDF